The University of Chicago Header Logo

Connection

Allison H. Bartlett to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Allison H. Bartlett has written about Cost-Benefit Analysis.
Allison H. Bartlett
Connection Strength
0.029
Cost-Benefit Analysis
  1. Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis. PLoS Negl Trop Dis. 2017 04; 11(4):e0005459.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.